These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28158479)

  • 41. The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada.
    Varas-Lorenzo C; Castellsague J; Stang MR; Perez-Gutthann S; Aguado J; Rodriguez LA
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1016-25. PubMed ID: 19718696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of short-term use of nonsteroidal anti-inflammatory drugs with stroke in patients with hypertension.
    Chuang SY; Yu Y; Sheu WH; Tsai YT; Liu X; Hsiung CA; Tsai HJ
    Stroke; 2015 Apr; 46(4):996-1003. PubMed ID: 25737315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients.
    Lee YC; Chang CH; Lin JW; Chen HC; Lin MS; Lai MS
    Liver Int; 2012 May; 32(5):859-66. PubMed ID: 22226322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studying additive interaction in a healthcare database: Case study of NSAIDs, cardiovascular profiles, and acute myocardial infarction.
    Bally M; Nadeau L; Brophy JM
    PLoS One; 2018; 13(8):e0201884. PubMed ID: 30096158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study.
    Chang YK; Liu JS; Hsu YH; Tarng DC; Hsu CC
    Medicine (Baltimore); 2015 Sep; 94(38):e1362. PubMed ID: 26402800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure.
    Evans JM; McGregor E; McMahon AD; McGilchrist MM; Jones MC; White G; McDevitt DG; MacDonald TM
    QJM; 1995 Aug; 88(8):551-7. PubMed ID: 7648241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular risk of nonsteroidal anti-inflammatory drugs in dialysis patients: a nationwide population-based study.
    Jo HA; Kim DK; Park S; Kim Y; Han SS; Yang BR; Choi SH; Kim MS; Lee J; Lee H; Lee JP; Lim CS; Kim YS; Joo KW
    Nephrol Dial Transplant; 2021 Apr; 36(5):909-917. PubMed ID: 31943085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study.
    Arfè A; Scotti L; Varas-Lorenzo C; Nicotra F; Zambon A; Kollhorst B; Schink T; Garbe E; Herings R; Straatman H; Schade R; Villa M; Lucchi S; Valkhoff V; Romio S; Thiessard F; Schuemie M; Pariente A; Sturkenboom M; Corrao G;
    BMJ; 2016 Sep; 354():i4857. PubMed ID: 27682515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exposure to nonsteroidal anti-inflammatory drugs among older adult patients hospitalized for peptic ulcer disease in Argentina: A case-control study.
    Insúa J; Mavros P; Hunsche E; Kong S; Tibaudin-Agver O
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):251-9. PubMed ID: 17062326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of Acute Cerebrovascular and Cardiovascular Events Among Users of Acetaminophen or an Acetaminophen-Codeine Combination in a Cohort of Patients with Osteoarthritis: A Nested Case-Control Study.
    Roberto G; Simonetti M; Piccinni C; Lora Aprile P; Cricelli I; Fanelli A; Cricelli C; Lapi F
    Pharmacotherapy; 2015 Oct; 35(10):899-909. PubMed ID: 26497476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study.
    Essers I; Stolwijk C; Boonen A; De Bruin ML; Bazelier MT; de Vries F; van Tubergen A
    Ann Rheum Dis; 2016 Jan; 75(1):203-9. PubMed ID: 25362044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ongoing treatment with non-steroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction.
    Lamberts M; Fosbøl EL; Olsen AM; Hansen ML; Folke F; Kristensen SL; Olesen JB; Hansen PR; Køber L; Torp-Pedersen C; Gislason GH
    Int J Cardiol; 2013 Sep; 168(2):832-7. PubMed ID: 23117013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study.
    Johnsen SP; Pedersen L; Friis S; Blot WJ; McLaughlin JK; Olsen JH; Sørensen HT
    Stroke; 2003 Feb; 34(2):387-91. PubMed ID: 12574547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study.
    Smyth A; O'Donnell M; Lamelas P; Teo K; Rangarajan S; Yusuf S;
    Circulation; 2016 Oct; 134(15):1059-1067. PubMed ID: 27753614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland.
    Helin-Salmivaara A; Virtanen A; Vesalainen R; Grönroos JM; Klaukka T; Idänpään-Heikkilä JE; Huupponen R
    Eur Heart J; 2006 Jul; 27(14):1657-63. PubMed ID: 16731535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.
    Hernández-Díaz S; Varas-Lorenzo C; García Rodríguez LA
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):266-74. PubMed ID: 16611201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An algorithm to identify incident myocardial infarction using Medicaid data.
    Choma NN; Griffin MR; Huang RL; Mitchel EF; Kaltenbach LA; Gideon P; Stratton SM; Roumie CL
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1064-71. PubMed ID: 19718697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
    Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
    JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.